TLR9 and neoplasm: The silencing of TLR9 in PC-TLR9LO cells resulted in ~200-fold reduction in the TPC frequency (Figure 1C, second panel) which corresponded to the previously observed delayed PC-TLR9LO tumor engraftment (Figure 1B, right).